Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18824511 | METHODS AND SYSTEMS FOR DETERMINING HEALTH OF AN ORGAN BASED ON MEDICAL IMAGE DATA USING ARTIFICIAL INTELLIGENCE | September 2024 | February 2025 | Allow | 5 | 1 | 1 | Yes | No |
| 18433199 | MANAGEMENT OF PHARMACY KITS USING MULTIPLE ACCEPTANCE CRITERIA FOR PHARMACY KIT SEGMENTS | February 2024 | June 2025 | Allow | 16 | 1 | 0 | No | No |
| 18417247 | Systems and Methods for Computing Measurements for Mitochondrial Diseases | January 2024 | March 2025 | Abandon | 14 | 1 | 0 | No | No |
| 18514211 | SYSTEM AND METHOD FOR SAFE AND ACCURATE SELF ADMINISTRATION OF MEDICATIONS | November 2023 | March 2025 | Allow | 16 | 2 | 0 | No | No |
| 18142411 | APPARATUS FOR POST ACTION PLANNING AND METHOD OF USE | May 2023 | November 2024 | Allow | 18 | 3 | 0 | Yes | No |
| 18304278 | DIAGNOSTIC COMMUNICATION SYSTEMS, DIAGNOSTIC DATA COLLECTION KITS, AND METHODS FOR GENERATING AND CONVEYING ORAL CONDITION DATA SETS AND TREATMENT PLANS | April 2023 | February 2025 | Abandon | 22 | 1 | 0 | No | No |
| 18248271 | REMOTE VENTILATION DASHBOARD SYSTEM | April 2023 | June 2025 | Abandon | 27 | 1 | 0 | No | No |
| 18109919 | Circadian Rhythm Recommendation Model Using Light Sensors and an Intelligent Light Box | February 2023 | April 2025 | Abandon | 26 | 1 | 0 | No | No |
| 18108279 | HEALTHCARE DELIVERY SYSTEM | February 2023 | June 2025 | Abandon | 28 | 3 | 0 | No | No |
| 18157799 | SYSTEMS AND METHODS FOR SELECTING A SCANNING DEVICE FOR AN OBJECT | January 2023 | June 2025 | Allow | 29 | 1 | 0 | No | No |
| 18156909 | PREDICTING TOLERABILITY IN AGGRESSIVE NON-HODGKIN LYMPHOMA | January 2023 | May 2025 | Allow | 28 | 1 | 0 | Yes | No |
| 17989046 | COPD MONITORING | November 2022 | May 2025 | Abandon | 30 | 1 | 0 | No | No |
| 17964427 | SYSTEM AND METHOD FOR SIMULTANEOUS GENERATION OF ELECTRONIC MEDICAL RECORDS FOR ARTIFICIAL INTELLIGENCE-ENABLED DYNAMIC IMAGE RECOGNITION | October 2022 | February 2025 | Abandon | 28 | 1 | 0 | No | No |
| 17937054 | WIRELESS CHARGING OF MEDICAL DEVICES | September 2022 | December 2024 | Allow | 26 | 1 | 0 | No | No |
| 17954113 | COMPUTING DEVICES PROGRAMMED FOR DYNAMIC ACTIVITY-ASSIGNMENT PROCESSING VIA WEARABLE DEVICES AND METHODS/SYSTEMS OF USE THEREOF | September 2022 | December 2024 | Abandon | 26 | 3 | 0 | No | No |
| 17887818 | PREDICTIVE AND INTERACTIVE DIAGNOSTIC SYSTEM | August 2022 | August 2024 | Allow | 24 | 5 | 0 | Yes | No |
| 17885714 | Automated Summarization of a Hospital Stay Using Machine Learning | August 2022 | September 2024 | Allow | 25 | 1 | 0 | No | No |
| 17681570 | UNIFIED DATA INTERFACE AND SYSTEM | February 2022 | August 2023 | Allow | 18 | 4 | 0 | Yes | No |
| 17575905 | SYSTEM AND METHOD FOR RANKING OPTIONS FOR MEDICAL TREATMENTS | January 2022 | April 2025 | Allow | 39 | 4 | 0 | No | Yes |
| 17619741 | DIAGNOSIS SUPPORT PROGRAM, DIAGNOSIS SUPPORT SYSTEM, AND DIAGNOSIS SUPPORT METHOD | December 2021 | December 2024 | Abandon | 36 | 1 | 0 | No | No |
| 17541399 | SYSTEMS AND METHODS FOR GENERATING A CANCER ALLEVIATION NOURISHMENT PLAN | December 2021 | May 2025 | Allow | 41 | 1 | 0 | Yes | No |
| 17393113 | ENSEMBLE MACHINE-LEARNING MODELS TO DETECT RESPIRATORY SYNDROMES | August 2021 | June 2025 | Allow | 46 | 3 | 0 | No | No |
| 17385672 | LOCATION-AWARE WELL-BEING INSIGHTS | July 2021 | November 2024 | Allow | 40 | 4 | 0 | Yes | No |
| 17380059 | SMART NUTRITION DOSING | July 2021 | October 2024 | Allow | 39 | 4 | 0 | Yes | No |
| 17414519 | COUNSELING METHOD AND COUNSELING DEVICE | June 2021 | October 2024 | Allow | 40 | 3 | 0 | Yes | No |
| 17144406 | BEHAVIOR MODIFICATION ASSISTANCE DEVICE, TERMINAL, AND SERVER | January 2021 | May 2025 | Abandon | 53 | 4 | 0 | Yes | No |
| 17136084 | SYSTEMS AND METHODS FOR GENERATING A CANCER ALLEVIATION NOURISHMENT PLAN | December 2020 | May 2025 | Allow | 52 | 8 | 0 | Yes | No |
| 16862643 | METHOD FOR ADJUSTING A BOLUS AMOUNT OF INSULIN, DEVICE AND MEDICAL SYSTEM | April 2020 | June 2024 | Allow | 50 | 3 | 0 | Yes | No |
| 15872977 | DIALYSIS DEVICE | January 2018 | April 2020 | Allow | 27 | 0 | 0 | No | No |
| 15670475 | ELECTRONIC HEALTH RECORD WEB-BASED PLATFORM | August 2017 | December 2024 | Abandon | 60 | 7 | 0 | No | No |
| 15592071 | METHODS AND DEVICES FOR REDUCING TRANSFUSIONS DURING OR AFTER SURGERY AND FOR IMPROVING QUALITY OF LIFE AND FUNCTION IN CHRONIC DISEASE | May 2017 | July 2024 | Allow | 60 | 9 | 0 | No | No |
| 15395646 | SYSTEMS AND METHODS FOR GENERATING ELECTRONIC COMMUNICATIONS AND UPDATING ELECTRONIC DATABASES | December 2016 | March 2024 | Allow | 60 | 13 | 0 | Yes | No |
| 15142130 | SMART FITNESS TRACKER | April 2016 | May 2017 | Allow | 12 | 1 | 1 | Yes | No |
| 14836218 | Healthcare Facility Management and Information System | August 2015 | November 2018 | Allow | 39 | 1 | 0 | No | No |
| 14800318 | USER FRIENDLY MEDICAL RECORDS SYSTEMS, APPARATUSES AND METHODS | July 2015 | April 2020 | Allow | 57 | 3 | 0 | No | No |
| 12215696 | COMPLIANCE DATA FOR HEALTH-RELATED PROCEDURES | June 2008 | November 2011 | Allow | 40 | 2 | 0 | No | Yes |
| 12080426 | GENERATING OUTPUT DATA BASED ON PATIENT MONITORING | April 2008 | November 2011 | Allow | 43 | 2 | 0 | No | Yes |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner LAM, ELIZA ANNE.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 100.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
Examiner LAM, ELIZA ANNE works in Art Unit 3681 and has examined 34 patent applications in our dataset. With an allowance rate of 70.6%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 36 months.
Examiner LAM, ELIZA ANNE's allowance rate of 70.6% places them in the 25% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by LAM, ELIZA ANNE receive 3.00 office actions before reaching final disposition. This places the examiner in the 95% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by LAM, ELIZA ANNE is 36 months. This places the examiner in the 18% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +35.2% benefit to allowance rate for applications examined by LAM, ELIZA ANNE. This interview benefit is in the 86% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 16.7% of applications are subsequently allowed. This success rate is in the 8% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 20.0% of cases where such amendments are filed. This entry rate is in the 17% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
When applicants request a pre-appeal conference (PAC) with this examiner, 200.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 98% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.
This examiner withdraws rejections or reopens prosecution in 100.0% of appeals filed. This is in the 98% percentile among all examiners. Of these withdrawals, 100.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.
When applicants file petitions regarding this examiner's actions, 0.0% are granted (fully or in part). This grant rate is in the 5% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 36% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 36% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.